Horst Ebhardt, Partner, Wolf Theiss and Ron Given, Partner, Wolf Theiss, discuss perceptions and challenges within the CEE region, as well as drivers within the energy sector, divestments by major utility companies, corporate finance trends and the healthcare sector outlook.
With $260bn of deals announced in the first half, the global pharma industry has witnessed some landmark transactions. Surani Fernando, assistant editor at BioPharm Insight, talks tax inversions and asset swaps.
"This year will be a standout year for European private equity," announced Lennart Pettersson of White & Case at the private equity briefing co-hosted with Mergermarket in Stockholm. View the webcast of the IPO exits and acquisition finance panels from this event.
Ed Bridges, of financial communications advisor FTI Consulting, makes the case for US-style shareholder activism in Europe, and how boards should respond when an activist investor appears on the share register.
Deborah McBrearty of HCC Global, an insurance underwriter, provides an update on why the usage of warranty and indemnity policies have increased, and how it aids the success of M&A transactions in different jurisdictions.
Martin Mendelssohn, a partner at CMS, summarises the key findings from the law firm's annual study into the terms underpinning M&A deals in the US and Europe. He outlines the convergence across different European markets, the stark differences between US and European documentation as well as trends in the UK market.